Journal Mobile Options
Table of Contents
Vol. 215, No. 3, 2007
Issue release date: September 2007

Generalized Lichen Nitidus with Involvement of the Palms following Interferon α Treatment

Scheler M. · Proelss J. · Bräuninger W. · Bieber T. · Wenzel J.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Lichen nitidus is an uncommon dermatosis of unknown etiology. Here we present the case of a generalized lichen nitidus with involvement of the palms in a patient with hepatitis C after systemic treatment with interferon α and ribavirin. Furthermore in our patient we could show a strong lesional expression of MxA, a protein specifically induced by type I interferon. It is tempting to speculate that interferon α may be involved in the pathogenesis of lichen nitidus.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Pinkus F: Über eine neue knötchenförmige Hauteruption: Lichen nitidus. Arch Dermatol Syphilis 1907;85:11–36.

    External Resources

  2. Maeda M: A case of generalized lichen nitidus with Koebner’s phenomenon. J Dermatol 1994;21:273–277.
  3. Pinkus H, Shair HM: Koebner phenomenon in lichen nitidus; report of two cases. AMA Arch Derm Syphilol 1952;65:82–87.
  4. Weiss RM, Cohen AD: Lichen nitidus of the palms and soles. Arch Dermatol 1971;104:538–540.
  5. Buono PL, Kurtin SB: Lichen nitidus of the palms. Cutis 1978;22:74–76.
  6. De Eusebio Murillo E, Sanchez Yus E, Novo Lens R: Lichen nitidus of the palms: a case with peculiar histopathologic features. Am J Dermatopathol 1999;21:161–164.
  7. Bear CL, Willsteed EM, Zagarella SS: Lichen nitidus confined to one palm. Australas J Dermatol 1989;30:41–42.
  8. Yanez S, Val-Bernal JF: Purpuric generalized lichen nitidus: an unusual eruption simulating pigmented purpuric dermatosis. Dermatology 2004;208:167–170.
  9. Itami A, Ando I, Kukita A: Perforating lichen nitidus. Int J Dermatol 1994;33:382–384.
  10. Petrozzi JW, Shmunes E: Linear lichen nitidus. Cutis 1970;6:1109–1112.
  11. Al-Mutairi N, Hassanein A, Nour-Eldin O, Arun J: Generalized lichen nitidus. Pediatr Dermatol 2005;22:158–160.
  12. Smoller BR, Flynn TC: Immunohistochemical examination of lichen nitidus suggests that it is not a localized papular variant of lichen planus. J Am Acad Dermatol 1992;27:232–236.
  13. Mihara M, Nakayama H, Shimao S: Lichen nitidus: a histologic and electron microscopic study. J Dermatol 1991;18:475–480.
  14. Lapins NA, Willoughby C, Helwig EB: Lichen nitidus: a study of forty-three cases. Cutis 1978;21:634–637.
  15. Kubota Y, Kiryu H, Nakayama J: Generalized lichen nitidus successfully treated with an antituberculous agent. Br J Dermatol 2002;146:1081–1083.
  16. Randle HW, Sander HM: Treatment of generalized lichen nitidus with PUVA. Int J Dermatol 1986;25:330–331.
  17. Lucker GP, Koopman RJ, Steijlen PM, van der Valk PG: Treatment of palmoplantar lichen nitidus with acitretin. Br J Dermatol 1994;130:791–793.
  18. Marks R, Jones EW: Familial lichen nitidus: the simultaneous occurrence of lichen nitidus in brothers. Trans St Johns Hosp Dermatol Soc 1970;56:165–167.
  19. Lestringant GG, Piletta P, Feldmann R, Galadari I, Frossard PM, Saurat JH: Coexistence of atopic dermatitis and lichen nitidus in three patients. Dermatology 1996;192:171–173.
  20. Scheinfeld NS, Teplitz E, McClain SA: Crohn’s disease and lichen nitidus: a case report and comparison of common histopathologic features. Inflamm Bowel Dis 2001;7:314–318.
  21. Fanti PA, Tosti A, Morelli R, Bardazzi F: Lichen planus of the nails with giant cells: lichen nitidus? Br J Dermatol 1991;125:194–195.
  22. Aram H: Association of lichen planus and lichen nitidus: treatment with etretinate. Int J Dermatol 1988;27:117.
  23. Kawakami T, Soma Y: Generalized lichen nitidus appearing subsequent to lichen planus. J Dermatol 1995;22:434–437.
  24. Aydingoz IE, Ozcivan M, Mansur T: The role of hepatitis C virus infection in patients with chronic generalized pruritus. Dermatology 2005;211:170–171.
  25. Wilson HT, Bett DC: Miliary lesions in lichen planus. Arch Dermatol 1961;83:920–923.
  26. Ichimura M, Hiratsuka K, Ogura N, Utsunomiya T, Sakamaki H, Kondoh T, Abiko Y, Otake S, Yamamoto M: Expression profile of chemokines and chemokine receptors in epithelial cell layers of oral lichen planus. J Oral Pathol Med 2006;35:167–174.
  27. Wenzel J, Scheler M, Proelss J, Bieber T, Tuting T: Type I interferon-associated cytotoxic inflammation in lichen planus. J Cutan Pathol 2006;33:672–678.
  28. Fetil E, Ozkan S, Gurler N, Polat E, Yurtsever S, Dorak F, Kupelioglu A: Lichen nitidus after hepatitis B vaccine. Int J Dermatol 2004;43:956–958.
  29. Pinto JM, Marques MS, Correia TE: Lichen planus and leukocytoclastic vasculitis induced by interferon alpha-2b in a subject with HCV-related chronic active hepatitis. J Eur Acad Dermatol Venereol 2003;17:193–195.
  30. Guijarro Guijarro B, Lopez Sanchez AF, Hernandez Vallejo G: Presence of lichen planus during a course of interferon alpha-2a therapy for a viral chronic C hepatitis. Med Oral 2001;6:358–363.
  31. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK; Hepatitis Interventional Therapy Group: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339:1485–1492.
  32. Kerl K, Negro F, Lubbe J: Cutaneous side-effects of treatment of chronic hepatitis C by interferon alfa and ribavirin. Br J Dermatol 2003;149:656.
  33. Lubbe J, Kerl K, Negro F, Saurat JH: Clinical and immunological features of hepatitis C treatment-associated dermatitis in 36 prospective cases. Br J Dermatol 2005;153:1088–1090.
  34. Magro CM, Crowson AN: Lichenoid and granulomatous dermatitis. Int J Dermatol 2000;39:126–133.
  35. Souvignet C, Zarski JP: Combination treatment for chronic hepatitis C: what is the role of ribavirin? Fundam Clin Pharmacol 2000;14:321–325.


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00